机译:韩国原发性甲状腺淋巴瘤的临床特征
Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea;
Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea;
Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea;
Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea;
Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, Korea;
Division of Endocrinology, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea;
Division of Endocrinology, Department of Internal Medicine, Eulji University School of Medicine, Daejeon, Korea;
Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea;
Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea;
primary lymphoma of thyroid; diffuse large B cell lymphoma; MALT lymphoma; fine needle aspiration cytology;
机译:韩国原发性甲状腺淋巴瘤的临床特征
机译:9218原发性非霍奇金氏甲状腺淋巴瘤的临床和形态特征
机译:韩国胃癌筛查时发现的原发性胃淋巴瘤的临床特征
机译:初级皮肤B细胞淋巴瘤的临床方面和病理学。
机译:免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性:RU051417I-R-ICE(利妥昔单抗-异环磷酰胺-卡铂-依托泊苷)与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤(DLBCL)。
机译:韩国原发性骨淋巴瘤的临床特征和结局
机译:一家韩国机构的原发性系统间变性大细胞淋巴瘤:临床特征和治疗结果。